Metabolic complications of hepatitis C virus infection R Chaudhari, S Fouda, A Sainu, JM Pappachan World journal of gastroenterology 27 (13), 1267, 2021 | 54 | 2021 |
Matrine protects against MCD-induced development of NASH via upregulating HSP72 and downregulating mTOR in a manner distinctive from metformin A Mahzari, S Li, X Zhou, D Li, S Fouda, M Alhomrani, W Alzahrani, ... Frontiers in Pharmacology 10, 405, 2019 | 27 | 2019 |
Involvement of the autophagy-ER stress axis in high fat/carbohydrate diet-induced nonalcoholic fatty liver disease X Zhou, S Fouda, D Li, K Zhang, JM Ye Nutrients 12 (9), 2626, 2020 | 19 | 2020 |
Characterization of the therapeutic profile of albiflorin for the metabolic syndrome X Zhou, S Fouda, XY Zeng, D Li, K Zhang, J Xu, JM Ye Frontiers in pharmacology 10, 1151, 2019 | 17 | 2019 |
Management of metabolic-associated fatty liver disease: The diabetology perspective MS Jeeyavudeen, SKA Khan, S Fouda, JM Pappachan World Journal of Gastroenterology 29 (1), 126, 2023 | 12 | 2023 |
Pregnancy and metabolic-associated fatty liver disease: a clinical update S Fouda, MM Vennikandam, JM Pappachan, CJ Fernandez Journal of Clinical and Translational Hepatology 10 (5), 947, 2022 | 8 | 2022 |
Exposure to cigarette smoke precipitates simple hepatosteatosis to NASH in high-fat diet fed mice by inducing oxidative stress S Fouda, A Khan, SMH Chan, A Mahzari, X Zhou, CX Qin, R Vlahos, ... Clinical science 135 (17), 2103-2119, 2021 | 8 | 2021 |
Cigarette smoking blocks the benefit from reduced weight gain for insulin action by shifting lipids deposition to muscle A Khan, S Fouda, A Mahzari, SMH Chan, X Zhou, C Ratnam, R Vlahos, ... Clinical Science 134 (13), 1659-1673, 2020 | 7 | 2020 |
Pathobiology of Metabolic-Associated Fatty Liver Disease S Fouda, MS Jeeyavudeen, JM Pappachan, V Jayanthi Endocrinology and Metabolism Clinics 52 (3), 405-416, 2023 | 5 | 2023 |
Clinical implications of COVID-19 in patients with metabolic-associated fatty liver disease MS Jeeyavudeen, R Chaudhari, JM Pappachan, S Fouda World Journal of Gastroenterology 29 (3), 487, 2023 | 4 | 2023 |
Emerging roles of non-coding RNAs in colorectal cancer oxaliplatin resistance and liquid biopsy potential ZD Luo, YF Wang, YX Zhao, LC Yu, T Li, YJ Fan, SJ Zeng, YL Zhang, ... World Journal of Gastroenterology 29 (1), 1, 2023 | 2 | 2023 |
Preconditioning lessens high fat induced metabolic syndrome along with markers of increased metabolic capacity in muscle and adipose tissue S Li, X Zhou, E Jo, A Mahzari, S Fouda, D Li, K Zhang, JM Ye Bioscience reports 38 (6), BSR20181873, 2018 | 2 | 2018 |
Metabolic-Associated Fatty Liver Disease: A Disastrous Human Health Challenge. S Fouda, JM Pappachan Endocrinology and Metabolism Clinics of North America 52 (3), xv-xvi, 2023 | 1 | 2023 |
WJH KJ Dabos World 16 (2), 112-114, 2024 | | 2024 |
Metabolic-associated fatty liver disease and sarcopenia: A double whammy A Viswanath, S Fouda, CJ Fernandez, JM Pappachan World Journal of Hepatology 16 (2), 152, 2024 | | 2024 |
How does cigarette smoking aggravate hepatic steatosis to non-alcoholic steatohepatitis? SMA FOUDA RMIT University, 2021 | | 2021 |
Cigarette smoking causes glucose intolerance with involvement of the wasting and insulin resistance in muscle A Khan, S Fouda, A Mahzari, S Chan, R Vlahos, J Ye AUSTRALASIAN JOURNAL ON AGEING 39, 50-50, 2020 | | 2020 |
Legacy effects of high fat preconditioning against metabolic syndrome with enhanced metabolic capacity in muscle and adipose tissue J Ye, X Zhou, S Li, E Jo, A Mahzari, S Fouda Obesity Research & Clinical Practice 13 (3), 299, 2019 | | 2019 |
Preconditioning lessens high fat induced metabolic syndrome along with markers of increased metabolic capacity in muscle and adipose tissue. LSP Li SongPei, ZX Zhou Xiu, JEJ Jo EunJung, A Mahzari, S Fouda, ... | | 2018 |
Repurposing matrine for the treatment of non-alcoholic fatty liver disease AMA Mahzari RMIT University, 2018 | | 2018 |